248 related articles for article (PubMed ID: 37240178)
1. The Comprehensive Analysis of Specific Proteins as Novel Biomarkers Involved in the Diagnosis and Progression of Gastric Cancer.
Pawluczuk E; Łukaszewicz-Zając M; Mroczko B
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240178
[TBL] [Abstract][Full Text] [Related]
2. Identified a disintegrin and metalloproteinase with thrombospondin motifs 6 serve as a novel gastric cancer prognostic biomarker by bioinformatics analysis.
Zhu YZ; Liu Y; Liao XW; Luo SS
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33851708
[TBL] [Abstract][Full Text] [Related]
3. Exploring Potential Biomarkers in Oesophageal Cancer: A Comprehensive Analysis.
Romanowicz A; Lukaszewicz-Zajac M; Mroczko B
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673838
[TBL] [Abstract][Full Text] [Related]
4. The Role of Chemokines in the Development of Gastric Cancer - Diagnostic and Therapeutic Implications.
Pawluczuk E; Łukaszewicz-Zając M; Mroczko B
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33182840
[TBL] [Abstract][Full Text] [Related]
5. Gastric cancer - The role of matrix metalloproteinases in tumor progression.
Lukaszewicz-Zając M; Mroczko B; Szmitkowski M
Clin Chim Acta; 2011 Sep; 412(19-20):1725-30. PubMed ID: 21693112
[TBL] [Abstract][Full Text] [Related]
6. Matrix Metalloproteinases and Their Tissue Inhibitors in Comparison to Other Inflammatory Proteins in Gastric Cancer (GC).
Łukaszewicz-Zając M; Szmitkowski M; Litman-Zawadzka A; Mroczko B
Cancer Invest; 2016 Aug; 34(7):305-12. PubMed ID: 27414231
[TBL] [Abstract][Full Text] [Related]
7. Comparison between clinical significance of serum proinflammatory proteins (IL-6 and CRP) and classic tumor markers (CEA and CA 19-9) in gastric cancer.
Lukaszewicz-Zając M; Mroczko B; Gryko M; Kędra B; Szmitkowski M
Clin Exp Med; 2011 Jun; 11(2):89-96. PubMed ID: 20938721
[TBL] [Abstract][Full Text] [Related]
8. Serum CXCL8 and Its Specific Receptor (CXCR2) in Gastric Cancer.
Pawluczuk E; Łukaszewicz-Zając M; Gryko M; Kulczyńska-Przybik A; Mroczko B
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680333
[TBL] [Abstract][Full Text] [Related]
9. Expression of the matrix metalloproteases 2, 14, 24, and 25 and tissue inhibitor 3 as potential molecular markers in advanced human gastric cancer.
de la Peña S; Sampieri CL; Ochoa-Lara M; León-Córdoba K; Remes-Troche JM
Dis Markers; 2014; 2014():285906. PubMed ID: 24669030
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of both VEGF-A and VEGF-C in gastric cancer correlates with prognosis, and silencing of both is effective to inhibit cancer growth.
Wang X; Chen X; Fang J; Yang C
Int J Clin Exp Pathol; 2013; 6(4):586-97. PubMed ID: 23573305
[TBL] [Abstract][Full Text] [Related]
11. Gene methylation in gastric cancer.
Qu Y; Dang S; Hou P
Clin Chim Acta; 2013 Sep; 424():53-65. PubMed ID: 23669186
[TBL] [Abstract][Full Text] [Related]
12. A Disintegrin and Metalloproteinase 8 as a Potential Blood Biomarker for Early Diagnosis of Gastric Cancer.
Chung HW; Kim JJ; Choi JI; Lee HR; Lim JB
Yonsei Med J; 2019 Aug; 60(8):713-719. PubMed ID: 31347325
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of miRNAs as a signature for diagnosis and prognosis of gastric cancer and their involvement in the mechanism underlying gastric carcinogenesis and progression.
Ahadi A
IUBMB Life; 2020 May; 72(5):884-898. PubMed ID: 32078236
[TBL] [Abstract][Full Text] [Related]
14. Novel potential biomarkers for pancreatic cancer - A systematic review.
Litman-Zawadzka A; Łukaszewicz-Zając M; Mroczko B
Adv Med Sci; 2019 Sep; 64(2):252-257. PubMed ID: 30844662
[TBL] [Abstract][Full Text] [Related]
15. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
16. Coexpression of Matrix Metalloproteinase-7 and Tissue Inhibitor of Metalloproteinase-1 as a Prognostic Biomarker in Gastric Cancer.
Zhang Y; Qin L; Ma X; Wang Y; Wu Y; Jiang J
Dis Markers; 2020; 2020():8831466. PubMed ID: 33005257
[TBL] [Abstract][Full Text] [Related]
17. Correlation between Vascular Endothelial Growth Factor and Somatostatin Receptor with Progression and Prognosis in Gastric Cancer.
Zhao DQ; Chen J; Wu YF; Tian D; Zhou RX
Hepatogastroenterology; 2014 Jun; 61(132):1154-8. PubMed ID: 26158180
[TBL] [Abstract][Full Text] [Related]
18. Double-positive expression of high-mobility group box 1 and vascular endothelial growth factor C indicates a poorer prognosis in gastric cancer patients.
He W; Tang B; Yang D; Li Y; Song W; Cheang T; Chen X; Li Y; Chen L; Zhan W; Li W; He Y
World J Surg Oncol; 2013 Jul; 11():161. PubMed ID: 23866030
[TBL] [Abstract][Full Text] [Related]
19. DEK Is a Potential Biomarker Associated with Malignant Phenotype in Gastric Cancer Tissues and Plasma.
Lee KF; Tsai MM; Tsai CY; Huang CG; Ou YH; Hsieh CC; Hsieh HL; Wang CS; Lin KH
Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31766266
[TBL] [Abstract][Full Text] [Related]
20. [The role of interleukin-6 and C-reactive protein in gastric cancer].
Łukaszewicz-Zajac M; Mroczko B; Szmitkowski M
Pol Merkur Lekarski; 2010 Dec; 29(174):382-6. PubMed ID: 21298990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]